Phase I clinical trial of melphalan and 41.8 degrees C whole-body hyperthermia in cancer patients. - Concepedia

Concepedia

Publication | Closed Access

Phase I clinical trial of melphalan and 41.8 degrees C whole-body hyperthermia in cancer patients.

99

Citations

16

References

1997

Year

H. Ian Robins, Daniel A. Rushing, M Kutz, K D Tutsch, Cynthia L. Tiggelaar, Diane Β. Paul, David R. Spriggs, Carlye Kraemer, W. Gillis, C Feierabend,

Journal of Clinical Oncology

Abstract

We conclude that L-PAM with 41.8 degrees C WBH is well tolerated. Clinical results are consistent with preclinical predictions and provide a foundation for second-generation trials now in progress.

References

	Year	Citations

Page 1